XML 62 R47.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders' Equity (Narrative) (Details) - USD ($)
12 Months Ended
Sep. 10, 2021
Dec. 28, 2021
Sep. 28, 2021
Sep. 29, 2020
Aug. 13, 2021
Schedule Of Stockholders Equity [Line Items]          
Preferred stock, shares authorized     5,000,000 5,000,000  
Common stock, shares authorized     50,000,000 50,000,000  
Common stock, shares outstanding     12,512,072 12,612,852  
Common stock, par value     $ 0.001 $ 0.001  
Issuance of common shares and warrants in public offering, shares       2,413  
Stock based compensation expense     $ 283,000 $ 362,000  
Stock option exercise, shares     187,291    
Proceeds from stock option exercises     $ 440,000  
Aggregate intrinsic value of outstanding options     723,000    
Aggregate intrinsic value of exercisable options     634,000    
Other accrued liabilities     $ 169,000    
Maximum number of common stock shares that could be repurchased through Tender Offer         1,413,000
Maximum number of common stock shares that could be repurchased through Tender Offer, purchase price per share         $ 4.60
Number of shares repurchased through Tender Offer 333,241        
Purchase price of shares repurchased through Tender Offer $ 4.60        
Cost of shares repurchased through Tender Offer $ 1,532,908        
Common Stock [Member]          
Schedule Of Stockholders Equity [Line Items]          
Stock option exercise, shares     184,682 2,413  
Restricted Stock [Member]          
Schedule Of Stockholders Equity [Line Items]          
Restricted stock granted, shares       60,336  
Vesting period       3 years  
Remaining total unrecognized compensation cost related to unvested stock-based arrangements     $ 36,000    
Employee service share-based compensation, nonvested awards, total compensation cost not yet recognized, period for recognition     11 months 12 days    
Restricted Stock [Member] | Transaction One [Member]          
Schedule Of Stockholders Equity [Line Items]          
Restricted stock granted, shares     46,336    
Restricted stock granted, weighted average grant date fair value per share     $ 1.54    
Restricted Stock [Member] | Transaction Two [Member]          
Schedule Of Stockholders Equity [Line Items]          
Restricted stock granted, shares     14,000    
Restricted stock granted, weighted average grant date fair value per share     $ 1.67    
Stock Options [Member]          
Schedule Of Stockholders Equity [Line Items]          
Stock options granted, shares     90,000    
Stock options granted, exercise price     $ 2.33    
Remaining total unrecognized compensation cost related to unvested stock-based arrangements     $ 98,000    
Employee service share-based compensation, nonvested awards, total compensation cost not yet recognized, period for recognition     1 year 10 months 24 days    
Stock option exercise, shares     187,291 15,646  
Chief Executive Officer [Member] | Stock Options [Member]          
Schedule Of Stockholders Equity [Line Items]          
Stock options granted, shares     90,000    
Stock options granted, exercise price     $ 2.33    
Stock options granted, per-share weighted average fair value     $ 1.22    
Chief Executive Officer [Member] | Performance shares [Member] | 2018 Plan [Member]          
Schedule Of Stockholders Equity [Line Items]          
Stock options granted, shares   10,000      
Stock options granted, per-share weighted average fair value   $ 2.77      
Directors and Officers [Member] | 2018 Plan [Member] | Common Stock [Member]          
Schedule Of Stockholders Equity [Line Items]          
Stock options granted, shares   12,948      
Stock options granted, per-share weighted average fair value   $ 2.78